BraveCX— 510(k) K223754

Substantially Equivalent

Bering, Ltd.

FDA 510(k) clearance K223754 for BraveCX, Substantially Equivalent on 2023-11-09. Applicant: Bering, Ltd..

Clearance details

Applicant: Bering, Ltd.
Product code: Code QFM
Advisory panel: Radiology
Date received: 2022-12-15
Decision date: 2023-11-09
Decision: Substantially Equivalent
Clearance type: Traditional
Location: London, GB

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.